SCHEMBL1375632

SCHEMBL1375632

c1c[nH]c([Si](c2ccc[nH]2)(c2ccc[nH]2)c2ccc[nH]2)c1

nearest known ligand 0.35

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
DAO P14920 1/20 0.35
HDAC8 Q9BY41 1/20 0.35
HDAC6 Q9UBN7 1/20 0.35
AURKA O14965 1/20 0.35
AURKB Q96GD4 1/20 0.35
INCENP Q9NQS7 1/20 0.35
FKBP5 Q13451 1/20 0.33
MCL1 Q07820 1/20 0.31
NAPRT Q6XQN6 1/20 0.31
KDM4E B2RXH2 1/20 0.30
GAA P10253 1/20 0.30
MAPT P10636 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2180074 0.77
SCHEMBL28399974 0.77 DAO (0.32) DAOHDAC8HDAC6AURKAAURKB
SCHEMBL4966261 0.77 AURKA (0.37) DAOHDAC8HDAC6AURKAAURKB
SCHEMBL3796424 0.77
SCHEMBL7169327 0.73 TAAR1 (0.32) DAOHDAC8HDAC6AURKAAURKB
SCHEMBL17633740 0.71 ALDH1A1 (0.31)
SCHEMBL31568743 0.71 ESR1 (0.33)
SCHEMBL5701122 0.69 NR1H2 (0.31)
SCHEMBL31722305 0.69
SCHEMBL31722380 0.69 HDAC8 (0.32) HDAC8HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8399695-B2 Organometallic precursor compounds PRAXAIR TECHNOLOGY, INC. (US) 2013-03-19 US claimed
US-20110293852-A1 ORGANOMETALLIC PRECURSOR COMPOUNDS PRAXAIR TECHNOLOGY, INC. 2011-12-01 US claimed
US-7332618-B2 Organometallic precursor compounds PRAXAIR TECHNOLOGY, INC. (US) 2008-02-19 US claimed
EP-1805195-A2 ORGANOMETALLIC PRECURSOR COMPOUNDS PRAXAIR TECHNOLOGY, INC. (US) 2007-07-11 EP claimed
WO-2006036538-A2 ORGANOMETALLIC PRECURSOR COMPOUNDS PRAXAIR TECHNOLOGY, INC. (US) 2006-04-06 WO claimed
US-20060068102-A1 Organometallic precursor compounds PRAXAIR TECHNOLOGY, INC. 2006-03-30 US claimed
US-8399695-B2 Organometallic precursor compounds PRAXAIR TECHNOLOGY, INC. (US) 2013-03-19 US disclosed
US-20110293852-A1 ORGANOMETALLIC PRECURSOR COMPOUNDS PRAXAIR TECHNOLOGY, INC. 2011-12-01 US disclosed
US-7332618-B2 Organometallic precursor compounds PRAXAIR TECHNOLOGY, INC. (US) 2008-02-19 US disclosed
EP-1805195-A2 ORGANOMETALLIC PRECURSOR COMPOUNDS PRAXAIR TECHNOLOGY, INC. (US) 2007-07-11 EP disclosed
WO-2006036538-A2 ORGANOMETALLIC PRECURSOR COMPOUNDS PRAXAIR TECHNOLOGY, INC. (US) 2006-04-06 WO disclosed
US-20060068102-A1 Organometallic precursor compounds PRAXAIR TECHNOLOGY, INC. 2006-03-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110293852-A1 ORGANOMETALLIC PRECURSOR COMPOUNDS MSMO1, NNMT, DNMT1 DAO 885/4885HDAC8 4059/4885HDAC6 3811/4885
US-20060068102-A1 Organometallic precursor compounds MSMO1, NNMT, DNMT1 DAO 885/4885HDAC8 4059/4885HDAC6 3811/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.